{"title":"Study of Central Nervous System Depressant and Behavioral Activity of Ethanolic Extract of Clitoria Annuain Albino Rats","authors":"Kalpana S, Shanawaz S, K. R, Ghousiya S, N. S","doi":"10.46795/ijhcbs.v4i2.454","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i2.454","url":null,"abstract":"Objective: The objective was to evaluate depressant effects on central nervous system (CNS) and behavioral effects of ethanol extract of clitoria annua and to find the phytochemical responsible for these activities with possible mode of action. Materials & Method: The central nervous system (CNS) depressant activity of C. annua was evaluated by the classical models of depression as Rota rod method, Actophotometer test, tail suspension, and thiopental sodium induced sleeping time tests in Rat. The Rats were divided into Normal, Standard, and two test groups containing five rats each. The test groups received extract at the doses of 200, and 400 mg/kg body weight orally where as the Normal group received distilled water (0.1 ml/mice, p.o.). Diazepam (2 mg/kg, i.p.) was used as standard drug. Results: It is clear that the plant extract significantly decreased the locomotor activity of rats in Rota rod method and Actophotometer test when compared to the normal (p < 0.05). It is observed that the extract showed significantly (p < 0.05) increased in immobility time in tail suspension test in mice. In addition, the extract produced prolongs the sleeping time with onset of action in contrast to the normal group. Conclusions: The present work depicts the evaluation of possible CNS depressant activity of C. annua in mice models. EECA can be a safe and effective approach/alternative for the treatment of number of CNS depressant disorders. More extensive study is required to fractionate, purify, and identify the exact mechanism of action CNS Depressant activity present in ethanolic extract of Clitoria annua with its active ingredients.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129954605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Isolation of Mucorspp from patients with otitis media and its sensitivity to antifungals","authors":"Kadhim H. A Al-Ameri, Ashjan Agar Nasser","doi":"10.46795/ijhcbs.v4i2.446","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i2.446","url":null,"abstract":"The current study dealt with patients with otitis media, where the fungus was isolated from different pathological conditions, and the patients were distributed according to age, sex, residence, and chronic diseases.The fungal species isolated from these patients were diagnosed, and the focus was on Mucor as it is dangerous and may cause black fungus disease, as it was diagnosed phenotypically and molecularly by polymerase chain reaction (PCR) and a drug sensitivity test was conducted. The results showed that men are more susceptible to infection than women, and adults are more susceptible than adolescents and children, and chronic diseases increased the incidence.The study showed an average ability of Mucor spp to produce hydrolytic enzymes, which makes it dangerous only for patients with low immunity. The study also showed that the fungus is resistant to antifungals except for fluconazole, amphotericin B, and ketoconazole, where the diameter of inhibition was 32, 14, and 10 mm, respectively.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"101 5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130721591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. B, Venkata Sri Alekhya S, S. V, R. K, Anwesh Deep Pady, V. K
{"title":"A short review on congenital adrenal hyperplasia","authors":"R. B, Venkata Sri Alekhya S, S. V, R. K, Anwesh Deep Pady, V. K","doi":"10.46795/ijhcbs.v4i2.442","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i2.442","url":null,"abstract":"Congenital adrenal hyperplasia describes a group of hereditary genetic disorders affecting adrenal glands. The two main types of CAH are classic and non-classic is diagnosed at birth and non classic is typically diagnosed during adolescence. Symptoms are life threatening associated with CAH , may include vomiting, diarrhoea, hypotension and hypoglycaemia .both males and females may have infertility or adrenal crisis with CAH. Treatment goals are to reduce excessive hormones and replace deficient ones.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122715598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A review on analytical method development and validation of Erlotinib","authors":"Mohana Vamsi Nuli","doi":"10.46795/ijhcbs.v4i1.433","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.433","url":null,"abstract":"In this review article determines the different analytical methods for the quantitative establishment of Erlotinib by using HPLC, HPLCMS, HPLC-UV, LC-MS/MS. Pharmaceutical analytical method development of Erlotinib requires valid analytical procedures for quantitative and qualitative analysis in Pharmaceuticals dosage formulations and human serum. This assessment explains that the superiority of the HPLC/LC-MS methods reviewed is based on the quantitative analysis of drugs in formulations, (API), biological fluids such as serum and plasma.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128233084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In -vitro pharmacological evaluation of ethanolic and hydroalcholic extracts of ocimum kilimandscharicum linn.leaves","authors":"M. A, L. P, Haseena P, Suchita N, Suhel S","doi":"10.46795/ijhcbs.v4i1.424","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.424","url":null,"abstract":"According to the Ayurveda, plants have been used for the treatment of so many diseases. Herbal drugs are easily available and have fewer side effects. So, many people are attracted towards the herbal drugs. Ocimum kilimandscharicum is one of a few types of basil that is perennial. It is a well-known plant in the Indian traditional system of medicine. The genus of Ocimum belongs to the family Labiatae and one of the most popular culinary herbs known for its medicinal properties. In this present study ethanolic, hydro alcoholic extract of Ocimum kilimandscharicum Linn was studied for Anti-coagulation activity using in-vitro model. The study revealed that different concentrations of the extract exhibited significant Anti-coagulation activity in a dose dependent manner at a concentration of 400mg/ml respectively and well compared with standard drug. Thus, it could that due to the presence of chemical constituents present in the extracts have well prospective for the management of Coagulation. This Knowledge will be useful in finding more potent above activity from the natural resources for the clinical development of activities and therapeutics.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130339628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adamu N, Jithendra Kumar N, V. N., S. P., S. P, Hareesh Kumar M, V. K, Swathi Krishna K
{"title":"Drugs prescribing pattern analysis of gastrointestinal disorders","authors":"Adamu N, Jithendra Kumar N, V. N., S. P., S. P, Hareesh Kumar M, V. K, Swathi Krishna K","doi":"10.46795/ijhcbs.v4i1.421","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.421","url":null,"abstract":"Aim: The aim of the study is to evaluate Clinical profile & Prescribing Patterns of Drugs in patients with gastrointestinal disorders. Materials and Methods: Patients who were diagnosed with gastrointestinal disorders of either gender and with an age of above 18 years were included in this study. Results: In our study we have observed over 120 cases of Gastro-Intestinal Disorders. All of them were suffering from either of the Gastrointestinal Disorders. 63.33% of the subjects were Male and 36.66% of the subjects were Female. Among the subjects belonging to age group 20-40 years, 14.16% were Male and 6.66% were Female. Among the subjects belonging to age group 40-60 years, 32.5% were Male and 11.66% were Female. Among the subjects belonging to age group 60-80 years, 17.5% were Male and 6.66% were Female. Among the subjects belonging to the age group above 80 years, 8.33% were Male and 2.5% were Female. Conclusion: In our study, we noticed that the incidence of GI disorders was more in males (63.33%) compared to females (36.66%) and also the people who were in the age of 40 to 60 years were more affected compared to the younger ones. We have also reported the alcoholics (45.83%) and smokers (46.66%) were more prone to gastritis (44.16%) and pancreatitis (24.16%) than the normal population.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115003112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Y, Rishitha M, N. S, Venu Babu A, Sumavi Sekhar J, V. M
{"title":"Treatment outcome on pulmonary tuberculosis and extra pulmonary tuberculosis in government general hospital, ongole","authors":"H. Y, Rishitha M, N. S, Venu Babu A, Sumavi Sekhar J, V. M","doi":"10.46795/ijhcbs.v4i1.420","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.420","url":null,"abstract":"Background: Tuberculosis is a global disease leading to cause death worldwide. The Revised National Tuberculosis Control Programme (RNTCP), Directly Observed Treatment Short Course (DOTS), was launched to reduce tuberculosis mortality, improve patient adherence to treatment, and prevent the development of drug resistance. The aim of this study was treatment outcome of tuberculosis. Treatment outcome is an important indication of tuberculosis control programme. \u0000Methodology: An ambispective observational study was conducted in a government general hospital from August 2019 to January 2020 on the treatment outcomes of PTB and EPTB in the 15 years and older age group, both males and females, on category I regimens. Patients with comorbidities like HIV, diabetes, and social habits like smoking were included. Record based TB diagnosed data (August 2019 to January 2020) are taken and asses their treatment outcome after 6months of complete therapy. The recorded and collected data were analysed to evaluate the success rate of treatment outcomes for PTB and EPTB. \u0000Results: A total of 350 subjects were enrolled in the study, of which 311 are included and 39 are excluded due to incomplete data. The study with age group of 15 and above years where males 218(70.10%) and females 93(29.90%). Total pulmonary tuberculosis cases are 277 (89.07%), and extrapulmonary tuberculosis cases are 34 (10.93%). Subjects with HIV 48(15.43%), Diabetes 54(17.37%) and Tobacco smoking 85(27.33%). The treatment outcome was observed as follows: cured 144 (46.30%), treatment completed 98 (31.51%), transfer out 10 (3.21%), died 27 (8.69%), treatment failure 7 (2.26%), treatment lost to follow-up 14 (4.50%), and treatment regimen changed 11 (3.53%). At the end of the treatment, the success rate was found to be 78%. \u0000Conclusion: This study shows that the TB patients' treatment success rate was 78%, which is slightly less than the RNTCP norms. The died rate was 8% which is higher than national average. Perhaps the services need to improve tuberculosis case detection in HIV patients, while cure rates have to be improved in RNTCP. EPTB case enrolment is very low, whereas the referral system has to improve its services. So that EPTB cases enrolment may increase its number. The early detection may enhance the cure rates in patients.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134528585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A review of analytical techniques for determination of metformin: present and perspectives","authors":"Anil Kumar Tallam, Sahithi Alapati, Mohana Vamsi Nuli","doi":"10.46795/ijhcbs.v4i1.417","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.417","url":null,"abstract":"Metformin is an oral anti-diabetic drug in preventing complications of type 2 diabetes and it is a good first-line therapy for an over-obese with type 2 diabetes, it is currently available in more than 60 countries worldwide. As a result of the importance of this oral hypoglycaemic agent in the treatment of non-insulin-dependent diabetes mellitus, which leads to end-stage renal disease, this work aims to compile the published analytical methods reported so far in the literature for the determination in biological samples and pharmaceutical formulations. This article narrates different techniques like high-performance liquid chromatography. It can be seen that high-performance liquid chromatography methods have been used extensively. Thus, this paper will help in the selection and development of proper analytical methodologies estimation of Metformin to achieve satisfactory results.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128746283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rushinaidu T, E. G, Satish Kumar achari L, Jnapika M, Krishnapriya L
{"title":"A review article on pcos and its impact on quality of life in women correlation with age, basal metabolic index and various factors","authors":"Rushinaidu T, E. G, Satish Kumar achari L, Jnapika M, Krishnapriya L","doi":"10.46795/ijhcbs.v4i1.409","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.409","url":null,"abstract":"Polycystic ovary syndrome (PCOS) is a hormonal disorder characterised by presence of oligomenorrhoea, anovulation and hyperandrogenism in females. PCOS mainly observed in women in adolescent age to pre-partum resulting in abortions. Symptoms mainly include irregular menstrual cycles, anovulation, acne, hirsutism and oligomenorrhea. The pathophysiology of PCOS involves the primary ovarian abnormalities, endocrine alterations and metabolic modifiers such as anti-Mullerian hormone, insulin resistance and chronic inflammation which causes metabolic disturbances and results hormone imbalance which results in hyperandrogenism therefore development of cysts in ovaries is observed. Diagnostic criteria are mainly done from the Rotterdam criteria of PCOSwhich includes mainly presence of menstrual irregularities, ultrasound scanning and Luteinizing Harmone (LH) and Follicle-stimulating hormone (FSH) ratio and raise of androgens level in body. Treatment options includes oral contraceptive pills, metformin therapy for insulin intolerance, local treatments for hirsutism by laser hair removal therapy, hormone replacement therapy for hyperandrogenism and acne. Non-pharmacological treatment includes diet changes, regular exercises and weight loss. Early diagnosis of PCOD can improve the quality of life and minimize the chances of causing cardiac problemsand further complications caused by PCOS such as hair loss, infertility and if left undiagnosed may result in uterus cancer.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114820900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A review on: medicated chewing gum","authors":"Ashwini Jadhav","doi":"10.46795/ijhcbs.v4i1.404","DOIUrl":"https://doi.org/10.46795/ijhcbs.v4i1.404","url":null,"abstract":"Chewing gums are the type of mobile drug delivery systems. It is useful by means of administering drugs either locally or systemically through, the oral cavity. The treated chewing gum has through the times gained adding acceptance as a medicine delivery system. As compare to that chewable tablets treated epoxies aren't supposed to be swallowed and it can be removed from the point of operation without resort to invasive means and treated biting gum. MCG is solid, single cure medication. The end of this review is to gives an overview of gum composition, manufacturing process, and characterization. Due to the failure of studies concerning the evaluation of the mechanical parcels of MCGs, lesser effect was placed on the available performance tests and procedures for the estimation of their mechanical and textural parcels. It can be used either for original (mucosal) treatment of mouth complaint or for systemic (transmucosal) delivery by direct intra oral immersion through the buccal mucosa.","PeriodicalId":187282,"journal":{"name":"International Journal of Health Care and Biological Sciences","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115161835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}